In this edition:
Nurse navigators to improve timely access to cancer treatment
NGS to guide cancer management
Real-world diagnosis/treatment timeframes for bladder cancer in Australia
BMI/adiposity/sarcopenia & melanoma immunotherapy outcomes
Time toxicity in second-line treatment for metastatic gastroesophageal cancer
OS according to metastasis site in de novo anal SCC
Upregulated GDF-15 with cachexia in head & neck cancer
ICIs in patients with melanoma & pre-existing autoimmune conditions
ICI-associated ototoxicity in melanoma
FAPI-46 PET imaging to predict immunotherapy outcomes
Please login below to download this issue (PDF)